Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Goldacre

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Nature|February 11, 2011
Harnessing value of dispersed critiquesBen Goldacre
The Lancet. Oncology|September 1, 2009
Media misinformation and health behavioursBen Goldacre
BMJ (Clinical Research Ed.)|February 14, 2014
Evidence on industry influence should be in the core medical curriculumBen Goldacre
BMJ (Clinical Research Ed.)|December 1, 2007
Behold the Christmas miracle of antioxidantsBen Goldacre
Clinical Trials (London, England)|February 5, 2014
Commentary on Berlin et alBen Goldacre
BMJ (Clinical Research Ed.)|March 24, 2007
How doctors can get behind the headlinesBen Goldacre
BMJ (Clinical Research Ed.)|September 8, 2007
Journalists: anything to declare?Ben Goldacre
Lancet (London, England)|November 21, 2007
Benefits and risks of homoeopathyBen Goldacre
BMJ (Clinical Research Ed.)|June 21, 2017
The WHO joint statement from funders on trials transparencyBen Goldacre
BMJ (Clinical Research Ed.)|December 1, 2009
Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? YesBen Goldacre
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Nature|February 11, 2011
Harnessing value of dispersed critiquesBen Goldacre
The Lancet. Oncology|September 1, 2009
Media misinformation and health behavioursBen Goldacre
BMJ (Clinical Research Ed.)|February 14, 2014
Evidence on industry influence should be in the core medical curriculumBen Goldacre
BMJ (Clinical Research Ed.)|December 1, 2007
Behold the Christmas miracle of antioxidantsBen Goldacre
Clinical Trials (London, England)|February 5, 2014
Commentary on Berlin et alBen Goldacre
BMJ (Clinical Research Ed.)|March 24, 2007
How doctors can get behind the headlinesBen Goldacre
BMJ (Clinical Research Ed.)|September 8, 2007
Journalists: anything to declare?Ben Goldacre
Lancet (London, England)|November 21, 2007
Benefits and risks of homoeopathyBen Goldacre
BMJ (Clinical Research Ed.)|June 21, 2017
The WHO joint statement from funders on trials transparencyBen Goldacre
BMJ (Clinical Research Ed.)|December 1, 2009
Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? YesBen Goldacre
Pageof 27